[ohhoe]

In terms of some of the cancer stuff, this can explain it way better than I can.

"But it can take weeks to identify drugs targeting cancer-causing mutations. Watson can do it in minutes and has in its database the findings of scientific papers and clinical trials on particular cancers and potential therapies."

http://www.businessinsider.com/r-ibms-watson-to-guide-cancer...

[i000]

As someone who works at the bioinformatics end of a clinical cancer sequencing operation, and someone familiar with the MSKCC operation (they are doing good work with their IMPACT assay) I have to say that the landscape of matching patients with drugs is so sparse (few drugs, few FDA-approved links, not enough trials) that no Watson is necessary, just basic string matching and a comprehensive high-quality up-to-date database (which does not exist and currently there are 10+ companies working on it)